ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
49
views
0
references
Top references
cited by
333
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,853
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Author(s):
M. Pavel
,
K. Öberg
,
M. Falconi
,
E.P. Krenning
,
A. Sundin
,
A. Perren
,
A. Berruti
Publication date
Created:
July 2020
Publication date
(Print):
July 2020
Journal:
Annals of Oncology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Psychiatric Research and Clinical Practice
Author and article information
Journal
Title:
Annals of Oncology
Abbreviated Title:
Annals of Oncology
Publisher:
Elsevier BV
ISSN (Print):
09237534
Publication date Created:
July 2020
Publication date (Print):
July 2020
Volume
: 31
Issue
: 7
Pages
: 844-860
Article
DOI:
10.1016/j.annonc.2020.03.304
PubMed ID:
32272208
SO-VID:
cde6a232-ed42-43f2-93c2-7e75e2089a08
Copyright ©
© 2020
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,853
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
Authors:
RE MILLER
,
A. Leary
,
CL Scott
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.
Authors:
David A. Kleiman
,
Toni Beninato
,
Samuel Sultan
…
Epidemiology of gastroenteropancreatic neuroendocrine tumours.
Authors:
Y Fraenkel
,
M K Kim
,
A Faggiano
…
See all similar
Cited by
323
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States
Authors:
Zihan Xu
,
Li WANG
,
Shuang Dai
…
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
Authors:
Andreas Venizelos
,
Hege Elvebakken
,
Aurel Perren
…
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
Authors:
Tetsuhide Ito
,
Toshihiko Masui
,
Izumi Komoto
…
See all cited by